Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Murphy

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3B S Youn, S M Zhang, E K Lee, et al.
AIDS (London, England)|December 28, 2000
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort StudyD H McDermott, M J Beecroft, C A Kleeberger, et al.
Science (New York, N.Y.)|February 24, 2001
Genetic polymorphism in CX3CR1 and risk of HIV diseaseD H McDermott, J S Colla, C A Kleeberger, et al.
Journal of Innate Immunity|March 8, 2016
CXCR1 Regulates Pulmonary Anti-Pseudomonas Host DefenseM Carevic, H Öz, K Fuchs, et al.
Journal of Virology|January 22, 2000
Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigenJ C de Quiros, W L Shupert, A C McNeil, et al.
Molecular Medicine (Cambridge, Mass.)|January 1, 1997
Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified riskP A Zimmerman, A Buckler-White, G Alkhatib, et al.
The Journal of Clinical Investigation|September 18, 1997
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressorsO J Cohen, M Vaccarezza, G K Lam, et al.
British Journal of Pharmacology|February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overviewStephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3B S Youn, S M Zhang, E K Lee, et al.
AIDS (London, England)|December 28, 2000
Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort StudyD H McDermott, M J Beecroft, C A Kleeberger, et al.
Science (New York, N.Y.)|February 24, 2001
Genetic polymorphism in CX3CR1 and risk of HIV diseaseD H McDermott, J S Colla, C A Kleeberger, et al.
Journal of Innate Immunity|March 8, 2016
CXCR1 Regulates Pulmonary Anti-Pseudomonas Host DefenseM Carevic, H Öz, K Fuchs, et al.
Journal of Virology|January 22, 2000
Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigenJ C de Quiros, W L Shupert, A C McNeil, et al.
Molecular Medicine (Cambridge, Mass.)|January 1, 1997
Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified riskP A Zimmerman, A Buckler-White, G Alkhatib, et al.
The Journal of Clinical Investigation|September 18, 1997
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressorsO J Cohen, M Vaccarezza, G K Lam, et al.
British Journal of Pharmacology|February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overviewStephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
Pageof 15